glutathion depression Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Glutamatergic System in Depression |

A study highlighted S100A1s ability to restore calcium cycling in cardiomyocytes, improving contractility in heart failure models, and gene therapy using AAV-S100A1 showed reduced fibrosis and hypertrophy in rodents (Rostami et al., 2025)

The acute toxicology in animal models appears relatively benign, but animal toxicology does not establish human safety across chronic exposure

In preclinical models, simultaneous deficiency in NAD+ and GSH is associated with accelerated mitochondrial dysfunction

B12, along with B6 and folate, help metabolize homocysteine levels

Recovery timelines shorten through enhanced cellular regeneration

Those would be prophylactic and curative effects, respectively